---
title: "Artivion to Participate in Upcoming Investor Conferences | AORT Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294107919.md"
description: "Artivion, Inc. (NYSE: AORT) announced it will participate in two upcoming investor conferences. Management will present at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026, with a live webcast available. Additionally, executives will attend meetings at the Needham Virtual MedTech & Diagnostics 1x1 Conference on August 11, 2026, though no webcast will be provided for this event."
datetime: "2026-07-28T12:10:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294107919.md)
  - [en](https://longbridge.com/en/news/294107919.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294107919.md)
---

# Artivion to Participate in Upcoming Investor Conferences | AORT Stock News

, /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.

Artivion's management team will present at the upcoming Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026 at the InterContinental Boston Hotel. The Company's presentation is scheduled to begin at 9:30 a.m. ET. A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page. An archived copy of the webcast will be available for 90 days on the same website.

Artivion management will also be participating in investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026. Due to the format of this event no webcast will be available.

**About Artivion, Inc.**

Headquartered in suburban Atlanta, Georgia, Artivion, Inc., is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.Artivion.com.

**Contacts:**

**Artivion**

**Gilmartin Group LLC**

Lance A. Berry

Brian Johnston

Executive Vice President,

Phone: 332-895-3222

Chief Operating Officer &

investors@artivion.com

Chief Financial Officer

  

Phone: 770-419-3355

  

SOURCE Artivion, Inc.

### Related Stocks

- [AORT.US](https://longbridge.com/en/quote/AORT.US.md)

## Related News & Research

- [Artivion SVP, General Counsel Jean F. Holloway disposes of 977 common shares for $27,834.73](https://longbridge.com/en/news/295714316.md)
- [Canaccord Genuity Sticks to Its Buy Rating for Artivion (AORT)](https://longbridge.com/en/news/295791330.md)
- [Vislink to Present at the Emerging Growth Conference on Wednesday, August 19, 2026 | VISL Stock News](https://longbridge.com/en/news/296109069.md)
- [Prairie Operating Co. Announces Second Quarter 2026 Earnings Conference Call | PROP Stock News](https://longbridge.com/en/news/296094468.md)
- [Disclosure of trading in own shares from August 10, 2026 to August 14, 2026 | NEXNY Stock News](https://longbridge.com/en/news/296074241.md)